Effect of coenzyme Q10 supplementation on statin-induced myalgias

American Journal of Cardiology

Volumn 110, Issue 4, 2012, Pages 526-529

  Bookstaver, David A ^a   Burkhalter, Nancy A ^a   Hatzigeorgiou, Christos ^a  

^a EISENHOWER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CREATINE KINASE; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; UBIQUINONE;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FEMALE; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; MYALGIA; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY PAIN RATING INDEX; SEX DIFFERENCE; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE;

DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; GEORGIA; HOSPITALS, MILITARY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MUSCULAR DISEASES; MUSCULOSKELETAL PAIN; PAIN MEASUREMENT; TREATMENT OUTCOME; UBIQUINONE; VITAMINS;

EID: 84864410939     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.04.026     Document Type: Article

References (23)

1. P.S. Phillips, R.H. Haas, S. Bannykh, S. Hathaway, N.L. Gray, B.J. Kimura, G.D. Vladutiu, J.D.F. England Scripps Mercy Clinical Research Center Statin-associated myopathy with normal creatine kinase levels Ann Intern Med 137 2002 581 585
2. L. Marcoff, P.D. Thompson The role of coenzyme Q10 in statin-associated myopathy A systematic review J Am Coll Cardiol 49 2007 2231 2237
3. S.R. Lalani, G.D. Vladutiu, K. Plunkett, T.E. Lotze, A.M. Adesina, F. Scaglia Isolated mitochondrial myopathy associated with muscle coenzyme Q10 deficiency Arch Neurol 62 2005 317 320
4. G. De Pinieux, P. Chariot, M. Ammi-Saïd, F. Louarn, J.L. Lejonc, A. Astier, B. Jacotot, R. Gherardi Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio Br J Clin Pharmacol 42 1996 333 337
5. O.P. Flint, B.A. Masters, R.E. Gregg, S.K. Durham Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro Toxicol Appl Pharmacol 145 1997 91 98
6. G. Ghirlanda, A. Oradei, A. Manto, S. Lippa, L. Uccioli, S. Caputo, A.V. Greco, G.P. Littarru Evidence of plasma CoQ10-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study J Clin Pharmacol 33 1993 226 229
7. A. Thibault, D. Samid, A.C. Tompkins, W.D. Figg, M.R. Cooper, R.J. Hohl, J. Trepel, B. Liang, N. Patronas, D.J. Venzon, E. Reed, C.E. Myers Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer Clin Cancer Res 2 1996 483 491
8. S.A. Mortensen, A. Leth, E. Agner, M. Rohde Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors Mol Aspects Med 18 Suppl 1997 s137 s144
9. Y. Miyake, A. Shouzu, M. Nishikawa, T. Yonemoto, H. Shimizu, S. Omoto, T. Hayakawa, M. Inada Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients Arzneim Forschung 49 1999 324 329
10. T. Rundek, A. Naini, R. Sacco, K. Coates, S. DiMauro Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke Arch Neurol 61 2004 889 892
11. H. Mabuchi, A. Nohara, J. Kobayashi, M.A. Kawashiri, S. Katsuda, A. Inazu, J. Koizumi Hokuriku Lipid Research Group Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study Atherosclerosis 195 2007 e182 e189
12. A.M. Bargossi, G. Gross, P.L. Fiorella, A. Gaddi, R. Di Giulio, M. Battino Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors Mol Aspects Med 15 Suppl 1994 s187 s193
13. C. Lamperti, A.B. Naini, V. Lucchini, A. Prelle, N. Bresolin, M. Moggio, M. Sciacco, P. Kaufmann, S. DiMauro Muscle coenzyme Q10 level in statin-related myopathy Arch Neurol 62 2005 1709 1712
14. R. Laaksonen, K. Jokelainen, T. Sahi, M.J. Tikkanen, J.J. Himberg Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans Clin Pharmacol Ther 57 1995 62 66
15. G. Caso, P. Kelly, M.A. McNurlan, W.E. Lawson Effect of coenzyme Q10 on myopathic symptoms in patients treated with statins Am J Cardiol 99 2007 1409 1412
16. J.M. Young, C.M. Florkowski, S.L. Molyneux, R.G. McEwan, C.M. Frampton, P.M. George, R.S. Scott Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia Am J Cardiol 100 2007 1400 1403
17. R. Melzack The short-form McGill Pain Questionnaire Pain 30 1987 191 197
18. SEARCH Collaborative Group E. Link, S. Parish, J. Armitage, L. Bowman, S. Heath, F. Matsuda, I. Gut, M. Lathrop, R. Collins SLCO1B1 variants and statin-induced myopathy - a genomewide study N Engl J Med 359 2008 789 799
19. D. Voora, S.H. Shah, I. Spasojevic, S. Ali, C.R. Reed, B.A. Salisbury, G.S. Ginsburg The SLCO1B1*5 genetic variant is associated with statin-induced side effects J Am Coll Cardiol 54 2009 1609 1616
20. G.D. Vladutiu, Z. Simmons, P.J. Isackson, M. Tarnopolsky, W.L. Peltier, A.C. Barboi, N. Sripathi, R.L. Wortmann, P.S. Phillips Genetic risk factors associated with lipid-lowering drug-induced myopathies Muscle Nerve 34 2006 153 162
21. E. Bruckert, G. Hayem, S. Dejager, C. Yau, B. Bėgaud Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study Cardiovasc Drugs Ther 19 2005 403 414
22. I. Pravst, K. Zmitek, J. Zmitek Coenzyme Q10 contents in foods and fortification strategies Crit Rev Food Sci Nutr 50 2010 269 280
23. M. Tomasetti, R. Alleva, M.D. Solenghi, G.P. Littarru Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis Biofactors 9 1999 231 240